Cargando…
Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study
BACKGROUND: In the elderly, chronic low-grade inflammation (inflammaging) is a risk factor for the development of aging-related diseases and frailty. Using data from several thousand Eastern Europeans aged 65 years and older, we investigated whether the serum levels of two proinflammatory factors, i...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891873/ https://www.ncbi.nlm.nih.gov/pubmed/27274758 http://dx.doi.org/10.1186/s12979-016-0076-x |
_version_ | 1782435339024990208 |
---|---|
author | Puzianowska-Kuźnicka, Monika Owczarz, Magdalena Wieczorowska-Tobis, Katarzyna Nadrowski, Pawel Chudek, Jerzy Slusarczyk, Przemyslaw Skalska, Anna Jonas, Marta Franek, Edward Mossakowska, Malgorzata |
author_facet | Puzianowska-Kuźnicka, Monika Owczarz, Magdalena Wieczorowska-Tobis, Katarzyna Nadrowski, Pawel Chudek, Jerzy Slusarczyk, Przemyslaw Skalska, Anna Jonas, Marta Franek, Edward Mossakowska, Malgorzata |
author_sort | Puzianowska-Kuźnicka, Monika |
collection | PubMed |
description | BACKGROUND: In the elderly, chronic low-grade inflammation (inflammaging) is a risk factor for the development of aging-related diseases and frailty. Using data from several thousand Eastern Europeans aged 65 years and older, we investigated whether the serum levels of two proinflammatory factors, interleukin-6 (IL-6) and C-reactive protein (CRP), were associated with physical and cognitive performance, and could predict mortality in successfully aging elderly. RESULTS: IL-6 and CRP levels systematically increased in an age-dependent manner in the entire study group (IL-6: n = 3496 individuals, p < 0.001 and CRP: n = 3632, p = 0.003), and in the subgroup of successfully aging individuals who had never been diagnosed with cardiovascular disease, myocardial infarction, stroke, type 2 diabetes, or cancer, and had a Mini Mental State Examination (MMSE) score ≥24 and a Katz Activities of Daily Living (ADL) score ≥5 (IL-6: n = 1258, p < 0.001 and CRP: n = 1312, p < 0.001). In the subgroup of individuals suffering from aging-related diseases/disability, only IL-6 increased with age (IL-6: n = 2238, p < 0.001 and CRP: n = 2320, p = 0.249). IL-6 and CRP levels were lower in successfully aging individuals than in the remaining study participants (both p < 0.001). Higher IL-6 and CRP levels were associated with poorer physical performance (lower ADL score) and poorer cognitive performance (lower MMSE score) (both p < 0.001). This association remained significant after adjusting for age, gender, BMI, lipids, estimated glomerular filtration rate, and smoking status. Longer survival was associated with lower concentrations of IL-6 and CRP not only in individuals with aging-related diseases/disability (HR = 1.063 per each pg/mL, 95 % CI: 1.052-1.074, p < 0.001 and HR = 1.020 per each mg/L, 95 % CI: 1.015-1.025, p < 0.001, respectively) but also in the successfully aging subgroup (HR = 1.163 per each pg/mL, 95 % CI: 1.128-1.199, p < 0.001 and HR = 1.074 per each mg/L, 95 % CI: 1.047-1.100, p < 0.001, respectively). These associations remained significant after adjusting for age, gender, BMI, lipids and smoking status. The Kaplan-Meier survival curves showed similar results (all p < 0.001). CONCLUSIONS: Both IL-6 and CRP levels were good predictors of physical and cognitive performance and the risk of mortality in both the entire elderly population and in successfully aging individuals. |
format | Online Article Text |
id | pubmed-4891873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48918732016-06-04 Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study Puzianowska-Kuźnicka, Monika Owczarz, Magdalena Wieczorowska-Tobis, Katarzyna Nadrowski, Pawel Chudek, Jerzy Slusarczyk, Przemyslaw Skalska, Anna Jonas, Marta Franek, Edward Mossakowska, Malgorzata Immun Ageing Research BACKGROUND: In the elderly, chronic low-grade inflammation (inflammaging) is a risk factor for the development of aging-related diseases and frailty. Using data from several thousand Eastern Europeans aged 65 years and older, we investigated whether the serum levels of two proinflammatory factors, interleukin-6 (IL-6) and C-reactive protein (CRP), were associated with physical and cognitive performance, and could predict mortality in successfully aging elderly. RESULTS: IL-6 and CRP levels systematically increased in an age-dependent manner in the entire study group (IL-6: n = 3496 individuals, p < 0.001 and CRP: n = 3632, p = 0.003), and in the subgroup of successfully aging individuals who had never been diagnosed with cardiovascular disease, myocardial infarction, stroke, type 2 diabetes, or cancer, and had a Mini Mental State Examination (MMSE) score ≥24 and a Katz Activities of Daily Living (ADL) score ≥5 (IL-6: n = 1258, p < 0.001 and CRP: n = 1312, p < 0.001). In the subgroup of individuals suffering from aging-related diseases/disability, only IL-6 increased with age (IL-6: n = 2238, p < 0.001 and CRP: n = 2320, p = 0.249). IL-6 and CRP levels were lower in successfully aging individuals than in the remaining study participants (both p < 0.001). Higher IL-6 and CRP levels were associated with poorer physical performance (lower ADL score) and poorer cognitive performance (lower MMSE score) (both p < 0.001). This association remained significant after adjusting for age, gender, BMI, lipids, estimated glomerular filtration rate, and smoking status. Longer survival was associated with lower concentrations of IL-6 and CRP not only in individuals with aging-related diseases/disability (HR = 1.063 per each pg/mL, 95 % CI: 1.052-1.074, p < 0.001 and HR = 1.020 per each mg/L, 95 % CI: 1.015-1.025, p < 0.001, respectively) but also in the successfully aging subgroup (HR = 1.163 per each pg/mL, 95 % CI: 1.128-1.199, p < 0.001 and HR = 1.074 per each mg/L, 95 % CI: 1.047-1.100, p < 0.001, respectively). These associations remained significant after adjusting for age, gender, BMI, lipids and smoking status. The Kaplan-Meier survival curves showed similar results (all p < 0.001). CONCLUSIONS: Both IL-6 and CRP levels were good predictors of physical and cognitive performance and the risk of mortality in both the entire elderly population and in successfully aging individuals. BioMed Central 2016-06-03 /pmc/articles/PMC4891873/ /pubmed/27274758 http://dx.doi.org/10.1186/s12979-016-0076-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Puzianowska-Kuźnicka, Monika Owczarz, Magdalena Wieczorowska-Tobis, Katarzyna Nadrowski, Pawel Chudek, Jerzy Slusarczyk, Przemyslaw Skalska, Anna Jonas, Marta Franek, Edward Mossakowska, Malgorzata Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study |
title | Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study |
title_full | Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study |
title_fullStr | Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study |
title_full_unstemmed | Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study |
title_short | Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study |
title_sort | interleukin-6 and c-reactive protein, successful aging, and mortality: the polsenior study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891873/ https://www.ncbi.nlm.nih.gov/pubmed/27274758 http://dx.doi.org/10.1186/s12979-016-0076-x |
work_keys_str_mv | AT puzianowskakuznickamonika interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy AT owczarzmagdalena interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy AT wieczorowskatobiskatarzyna interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy AT nadrowskipawel interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy AT chudekjerzy interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy AT slusarczykprzemyslaw interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy AT skalskaanna interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy AT jonasmarta interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy AT franekedward interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy AT mossakowskamalgorzata interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy |